Currently we test and support the following browsers:
Please note that this is not intended to be an exhaustive list of browsers that support web standards, nor a test of browser compliance, nor a side-by-side comparison of various manufacturers’ browsers.
Warwick AB, Kalapurakal JA, Ou S-S, Green DM, Norkool PA, Peterson SM, Breslow NE Portal hypertension in children with Wilms tumor: a report from the National Wilms Tumor Study Group. Int J Rad Oncol Biol Phys 77:210-6, 2010. PMCID:PMC2888002
Ehrlich PF, Ferrer FA, Ritchey ML, Anderson JR, Green DM, Grundy PE, Dome JS, Kalapurakal JA, Perlman EJ, Shamberger RC. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group. Ann Surg 250:642-8, 2009. PMCID: PMC3302661
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, Thomas PR, Grundy P, Green DM, D’Angio GJ. Intraoperative spillage of favorable histology Wilms tumor cells: influence of irradiation and chemotherapy regimens on abdominal recurrence. a report from the national Wilms tumor study group. Int J Radiat Oncol Biol Phys 76:201-206, 2010. PMCID: PMC2843421
Huang CC, Gadd S, Breslow N, Cutcliffe C, Sredni ST, Helenowski IB, Dome JS, Grundy PE, Green DM, Fritsch MK, Perlman EJ. Predicting relapse in favorable histology Wilms tumor using gene expression analysis: a report from the Renal Tumor Committee of the Children's Oncology Group. Clin Cancer Res 5:1770–8, 2009.
Klosky JL, Gamble HL, Spunt SS, Randolph-Frye ME, Green DM, Hudson MM, Human papillomavirus (HPV) vaccination in survivors of childhood cancer. Cancer 115:5627-5636, 2009. PMCID: PMC2801897
Hensley ML, Hagerty KL, Kewalramani T, Green DM, Meropol NJ, Wasserman TH, Cohen GI, Emami B, Gradishar WJ, Mitchell RB, Thigpen JT, Trotti A III, von Hoff D, Schuchter LM. American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–45, 2009.
Fernandez CV, Anderson J, Breslow NE, Dome JS, Grundy PE, Perlman EJ, Green DM; National Wilms Tumor Study Group/Children’s Oncology Group. Anthropomorphic measurements and event-free survival in patients with favorable histology Wilms tumor: a report from the Children’s Oncology Group. Pediatr Blood Cancer 2:254–8, 2009.
Green DM. Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors. J Clin Oncol 26:3297–8, 2008.
Feusner JH, Ritchey ML, Norkool PA, Takashima JR, Breslow NE, Green DM. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 50:242–5, 2008.
Lawless SCW, Verma P, Green DM, Mahoney MC. Mortality experiences among 15+ year survivors of childhood and adolescent cancers. Pediatr Blood Cancer 48:333-8, 2007.
Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PRM, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM, Donaldson M, Robert Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R, Tomlinson G, Huff V, Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 48:493-9, 2007.
Green DM. Controversies in the management of Wilms tumour -- immediate nephrectomy or delayed nephrectomy? Eur J Cancer 43:2453-6, 2007.
Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, Thomas PRM, D'Angio GJ, Green, DM. Radiation therapy for favorable histology Wilms tumor: Prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Rad Oncol Biol Phys 65:203-9, 2006.
Perlman EJ, Faria P, Soares A, Hoffer F, Sredni S, Ritchey M, Shamberger RC, Green D, Beckwith JB. Hyperplastic perilobar nephroblastomatosis: Long term survival of 52 patients. Pediatr Blood Cancer 46:203-21, 2006.
Shamberger RC, Haase GM, Argani P, Perlman EJ, Cotton CA, Takashima J, Green DM, Ritchey ML. Bilateral Wilms tumors with progressive or nonresponsive disease. J Pediatr Surg 41:652-7, 2006.
Sklar CA, Mertens AC, Mitby P, Whitton J, Stovall M, Kasper C, Mulder J, Green D, Nicholson HS, Yasui Y, Robison LL. Premature menopause in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98:890-6, 2006.
Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin MH, Beckwith JB, Shamberger RS, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green D. Treatment of anaplastic histology Wilms' Tumor: Results from the Fifth National National Wilms' Tumor Study. J Clin Oncol 24:2352-8, 2006.
Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol 174:1972-5, 2005.
Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Hamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PRM, Macklis R, Tomlinson G, Huff V, Green DM. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor. a report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312-21, 2005.